Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Rozera C, Cappellini GA, D'Agostino G, Santodonato L, Castiello L, Urbani F, Macchia I, Aricò E, Casorelli I, Sestili P, Montefiore E, Monque D, Carlei D, Napolitano M, Rizza P, Moschella F, Buccione C, Belli R, Proietti E, Pavan A, Marchetti P, Belardelli F, Capone I.
Rozera C, et al. Among authors: belardelli f.
J Transl Med. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5.
J Transl Med. 2015.
PMID: 25933939
Free PMC article.
Clinical Trial.